About ADARx Pharmaceuticals ADARx Pharmaceuticals, Inc. is a late-stage clinical biotechnology company dedicated to transforming cutting-edge science into next-generation RNA medicines across a wide ...

Bond yields are hitting levels that signal markets are concerned that, even if the economy continues to grow, it could lead ...

Total production for 2024 reached 267,232 GEO at current prices, a 13% increase when compared to 2023 at current prices and ...

In a report released today, Ross Seymore from Deutsche Bank maintained a Hold rating on Nvidia (NVDA – Research Report), with a price target ...

The stock market is facing three challenges that could make a sharp decline more likely in 2025, according to Goldman Sachs.

The biggest US tech stocks have enjoyed an earnings bonanza in the past two years, leading to their significant ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Multiple TIGIT clinical data readouts anticipated throughout 2025, including >400 patients from two Phase 2 trials and one Phase 1/2 ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

China's bond yields have plunged to all-time lows in recent weeks, drawing parallels to Japan's "lost decades," a long period ...

Nexus Industrial REIT (“Nexus” or the "REIT") (TSX: NXR.UN) announced today that it intends to release its financial results for the fourth quarter and year ended December 31, 2024, before the opening ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...